Eli Lily Tries to Extend Exclusivity on Cancer Drug

Facing the natural expiration of the patent on its highly profitable lung-cancer treatment Alimta, Eli Lily this month went to trial to defend a follow-on patent for the treatment.

Read more...

Visit other PMG Sites: